Market Overview

Top 4 NYSE Stocks In The Biotechnology Industry With The Highest ROA

Related CRL
Top 4 NYSE Stocks In The Medical Laboratories & Research Industry With The Highest ROE
Charles River Beats on Q2 Earnings & Revenues, Outlook Upped
Related SHP
ShangPharma Announces Completion of Merger
ShangPharma Shareholders Approve Merger Agreement
Allergan Reportedly Seeks Alternate Suitor (Fox Business)

Below are the top biotechnology stocks on the NYSE in terms of return on assets.

The trailing-twelve-month return on assets at Charles River Laboratories International (NYSE: CRL) is 7.63%. Charles River Laboratories' operating margin for the same period is 16.89%.

The trailing-twelve-month return on assets at Emergent BioSolutions (NYSE: EBS) is 7.42%. Emergent BioSolutions' revenue for the same period is $295.23 million.

The trailing-twelve-month return on assets at Cambrex (NYSE: CBM) is 6.20%. Cambrex had $33.52 million in total cash for the recent quarter.

The trailing-twelve-month return on assets at ShangPharma (NYSE: SHP) is 2.26%. ShangPharma's PEG ratio is 1.20.

Posted-In: Biotechnology Industry Highest ROA NYSETrading Ideas

 

Related Articles (CBM + CRL)

Around the Web, We're Loving...

Get Benzinga's Newsletters